PRA Health Sciences, Inc.
PRA Health Sciences, Inc., a contract research organization, provides outsourced clinical development and data solution services to the biotechnology and pharmaceutical industries worldwide. It operates in two segments: clinical research and data solutions that provides product research services and data analytics services. The company conducts clinical trials in the areas of pharmaceutical development, including oncology, immunology, the central nervous system, inflammation, respiratory, cardiometabolic, and infectious diseases. PRA Health Sciences, Inc. was formerly known as PRA International, Inc. and changed its name to PRA Health Sciences, Inc. in July 2014. The company was founded in 1976 and is based in Raleigh, North Carolina. PRA Health Sciences, Inc. operates as a subsidiary of ICON Public Limited Company.
Market Cap
$10.7B
Volume
437.1K
Cash and Equivalents
$690.3M
EBITDA
$435.2M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
$1.6B
Profit Margin
48.49%
52 Week High
$175.95
52 Week Low
$93.00
Dividend
N/A
Price / Book Value
6.87
Price / Earnings
50.53
Price / Tangible Book Value
-14.96
Enterprise Value
N/A
Enterprise Value / EBITDA
N/A
Operating Income
$303.2M
Return on Equity
16.02%
Return on Assets
4.76
Cash and Short Term Investments
$690.3M
Debt
$1.5B
Equity
$1.6B
Revenue
$3.3B
Unlevered FCF
$438.3M
Sector
Life Sciences Tools and Services
Category
N/A
Hedge Funds that own this stock
Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).
Upgrade to Yellowbrick PremiumYellowbrick Portfolios that own this stock
Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).
Upgrade to Yellowbrick Premium